KRMAYURVED Share Price | KRM Ayurveda Ltd Stock Analysis & Recommendation

Q: Why is KRM Ayurveda Ltd falling/rising?

As of 05-Sep, KRM Ayurveda Ltd's stock price is rising, currently at 287.85, reflecting an increase of 4.95 or 1.75%. This upward movement can be attributed to several factors. Firstly, the stock has outperformed its sector by 3.01% today, indicating strong relative performance. Additionally, there has been a notable increase in investor participation, with a delivery volume of 98,000 on September 3, which is up by 89.19% compared to the 5-day average delivery volume. This surge in trading activity suggests growing interest among investors.Moreover, the stock's current price is higher than its 5-day, 50-day, 100-day, and 200-day moving averages, although it is lower than the 20-day moving average. This positioning relative to moving averages can indicate a bullish trend. Overall, the combination of strong sector performance, increased investor participation, and favorable moving average comparisons contributes to the rise in KRM Ayurveda Ltd's stock price.

Q: What does KRM Ayurveda do?

Overview: KRM Ayurveda Ltd operates a network of hospitals and clinics in India and offers telemedicine consulting and sales, positioned in the healthcare services industry within the micro-cap market.History: KRM Ayurveda Limited was incorporated as a Private Limited Company on September 03, 2019, and later converted into a Public Limited Company on December 24, 2024. The latest quarterly results reported net sales and net profit for June 2026.Financial Snapshot: Most recent Net Sales: 32 Cr (Quarterly Results - Jun 2026) Most recent Net Profit: 9 Cr (Quarterly Results - Jun 2026) Market-cap value: INR 604 Cr (Micro Cap)Key Metrics: P/E: 30.00 Industry P/E: 67 Dividend Yield: 0.00% Debt-Equity: -0.41 Return on Equity: 17.54% Price-to-Book: 5.19 Contact Details: No Company Details Available Registrar Address: Not available.

Q: Who are the peers of the KRM Ayurveda?

Peers: The peers of KRM Ayurveda are 3B Blackbio, Laxmi Dental, Health X Platfor, Nureca, QMS Medical, Hemant Surgical, Prevest Denpro, and One Global Serv.Quality Snapshot: Excellent management risk is observed at Prevest Denpro and One Global Serv, while Average management risk is found at 3B Blackbio, Laxmi Dental, QMS Medical, Hemant Surgical, and the rest. Below Average management risk is present at Health X Platfor and Nureca. Growth is rated as Good for Laxmi Dental and Hemant Surgical, while Average growth is seen at 3B Blackbio, QMS Medical, and the rest. Below Average growth is noted for Health X Platfor and Nureca. Excellent capital structure is attributed to 3B Blackbio, Laxmi Dental, Health X Platfor, and Prevest Denpro, while Good capital structure is seen at Nureca and Hemant Surgical, and Average capital structure is noted for QMS Medical.Return Snapshot: The peer with the highest 1-year return is Nureca at 38.19%, while Laxmi Dental has the lowest at -42.71%. KRM Ayurveda's 1-year return is not available for comparison. Additionally, Hemant Surgical, Prevest Denpro, and One Global Serv have a six-month return of 0.00%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

93.0 k (-55.46%) Volume

Shareholding (Mar 2026)

FII

3.86%

Held by 5 FIIs

DII

3.34%

Held by 0 DIIs

Promoter

69.15%

Which are the latest news on KRM Ayurveda?

18-Sep-2026

No latest news for KRM Ayurveda found.

Why is KRM Ayurveda Ltd falling/rising?

06-Sep-2026

As of 05-Sep, KRM Ayurveda Ltd's stock price is rising to 287.85, driven by strong sector performance, increased investor participation, and favorable comparisons to moving averages, indicating a bullish trend.

View full answer

What does KRM Ayurveda do?

01-Sep-2026

KRM Ayurveda Ltd operates hospitals and clinics in India, offering telemedicine services. As of June 2026, it reported net sales of 32 Cr and a net profit of 9 Cr, with a market cap of INR 604 Cr.

View full answer

Who are the peers of the KRM Ayurveda?

01-Sep-2026

KRM Ayurveda's peers include 3B Blackbio, Laxmi Dental, Health X Platfor, Nureca, QMS Medical, Hemant Surgical, Prevest Denpro, and One Global Serv. Notable performance includes Nureca with the highest 1-year return at 38.19% and Laxmi Dental with the lowest at -42.71%.

View full answer

How big is KRM Ayurveda?

01-Sep-2026

As of 31st August, KRM Ayurveda Ltd has a market capitalization of 604.00 Cr, with recent net sales of 89.20 Cr and a net profit of 20.94 Cr. The company's shareholder's funds are 23.88 Cr, and total assets amount to 66.79 Cr as of March 2025.

View full answer

Compare KRM Ayurveda with Similar Stocks

Gaudium IVF Hemant Surgical Health X Platfor

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Healthcare Services

Market cap

INR 680 Cr (Micro Cap)

P/E

33.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.41

Return on Equity

17.54%

Price to Book

5.88

Revenue and Profits:

Net Sales:

32 Cr

(Quarterly Results - Jun 2026)

Net Profit:

9 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

27.79%

6 Months

64.14%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

KRM Ayurveda for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

6.09

Debt to EBITDA (avg)

1.66

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.14

Tax Ratio

24.73%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

7.20%

ROCE (avg)

41.70%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.79

EV to EBIT

21.00

EV to EBITDA

20.21

EV to Capital Employed

9.17

EV to Sales

6.06

PEG Ratio

Dividend Yield

ROCE (Latest)

43.66%

ROE (Latest)

17.54%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

KST

Dow Theory

Mildly Bullish

No Trend

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 5 FIIs (3.86%)

Promoter with highest holding

Puneet Dhawan (90.79%)

Highest Public shareholder

Shyam Sunder (0.81%)

Individual Investors Holdings

14.87%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 0.34% vs 30.56% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 16.26% vs 92.84% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32.32",
          "val2": "32.21",
          "chgp": "0.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.01",
          "val2": "10.99",
          "chgp": "9.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.06",
          "val2": "0.63",
          "chgp": "-90.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.08",
          "val2": "7.81",
          "chgp": "16.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "37.16%",
          "val2": "34.12%",
          "chgp": "3.04%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 10.28% vs 18.41% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is 46.19% vs 70.29% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "53.33",
          "val2": "48.36",
          "chgp": "10.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.54",
          "val2": "12.84",
          "chgp": "36.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.54",
          "val2": "1.59",
          "chgp": "-3.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "11.90",
          "val2": "8.14",
          "chgp": "46.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.89%",
          "val2": "26.55%",
          "chgp": "6.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Jun'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "80.68",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.85",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "1.65",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "17.22",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.80%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 32.84% vs 13.98% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 79.48% vs 228.74% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "101.69",
          "val2": "76.55",
          "chgp": "32.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.49",
          "val2": "18.74",
          "chgp": "62.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.25",
          "val2": "2.90",
          "chgp": "12.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "20.12",
          "val2": "11.21",
          "chgp": "79.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.98%",
          "val2": "24.48%",
          "chgp": "5.50%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

32.32

32.21

0.34%

Operating Profit (PBDIT) excl Other Income

12.01

10.99

9.28%

Interest

0.06

0.63

-90.48%

Exceptional Items

0.00

Standalone Net Profit

9.08

7.81

16.26%

Operating Profit Margin (Excl OI)

37.16%

34.12%

3.04%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 0.34% vs 30.56% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 16.26% vs 92.84% in Mar 2026

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Mar'26

Mar'26

Sep'25

Change(%)

Net Sales

53.33

48.36

10.28%

Operating Profit (PBDIT) excl Other Income

17.54

12.84

36.60%

Interest

1.54

1.59

-3.14%

Exceptional Items

0.00

Standalone Net Profit

11.90

8.14

46.19%

Operating Profit Margin (Excl OI)

32.89%

26.55%

6.34%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Mar 2026 is 10.28% vs 18.41% in Sep 2025

Standalone Net Profit

Growth in half year ended Mar 2026 is 46.19% vs 70.29% in Sep 2025

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Jun'26

Jun'26

Change(%)

Net Sales

80.68

Operating Profit (PBDIT) excl Other Income

24.85

Interest

1.65

Exceptional Items

0.00

Standalone Net Profit

17.22

Operating Profit Margin (Excl OI)

30.80%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

101.69

76.55

32.84%

Operating Profit (PBDIT) excl Other Income

30.49

18.74

62.70%

Interest

3.25

2.90

12.07%

Exceptional Items

0.00

Standalone Net Profit

20.12

11.21

79.48%

Operating Profit Margin (Excl OI)

29.98%

24.48%

5.50%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 32.84% vs 13.98% in Mar 2025

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 79.48% vs 228.74% in Mar 2025

All Annual Results

Company CV

About KRM Ayurveda Ltd

KRM Ayurveda Ltd

Micro Cap

Healthcare Services

KRM Ayurveda Limited was incorporated as a Private Limited Company as "KRM Ayurveda Private Limited" on September 03, 2019. Company was converted into a Public Limited Company and the name of Company was changed to "KRM Ayurveda Limited" on December 24, 2024. Company is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through tele medicines consulting and sales.

Company Coordinates

No Company Details Available